Impact of cardiovascular risk enrichment on incidence of major adverse cardiovascular events in the tofacitinib rheumatoid arthritis clinical programme
Related Posts
Mudnal PS, Chuang E, Lindly OJ, Needleman J, Ganz DA, Kuo AA. The Role of Screentime and Family Resiliency in Overweight/Obesity in Children and Children[...]
Lacy BE, Shin AS, Cangemi DJ, Yang Y, Zhao S, Rosenbaum DP. Tenapanor is associated with earlier and sustained symptom relief in IBS-C: a post[...]
Mohtashemi N, Spaczai J, Guo R, Tseng CH, Cambou MC, Emel L, Ship H, Zhang TH, Chiu SH, Stranix-Chibanda L, Chipato T, Kintu K, Manji[...]